Delivery Order SPE2DB22D3501-SPE2DB23FXD59
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 mg tablets and has a ceiling value of $11,348.06. The ultimate completion date for this contract is May 13, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of XIFAXAN 550 mg tablets. The contract has a total ceiling value of $10,400.65 and a completion date of August 21, 2024. The award was made under an Indefinite Delivery Contract (IDC) that DLA Troop Support Medical holds with AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XIFAXAN 550 mg tablets. The contract has a ceiling value of $35,853.83 and is a firm-fixed-price contract. The ultimate completion date is August 12, 2024. This contract is not a set-aside and is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $12,713.24. The contract is a firm fixed price delivery order with a performance period ending on May 22, 2025. The contract is not set aside and was open to full and open competition. AmerisourceBergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,931.33 and is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and a performance period through November 6, 2023. This order is associated with a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of XIFAXAN 550 MG TABLET 60S, a prescription pharmaceutical product. The order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a wide range of medical commodities to support military treatment programs and facilities worldwide. The delivery order has a ceiling value of $87,578.22 and a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of XIFAXAN 550 mg tablets, a prescription medication, to support various federal healthcare programs and facilities. The contract has a ceiling value of $12,766.79 and an ultimate completion date of September 24, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET UD 60S. The contract has a ceiling value of $2,825.09 and is a firm fixed-price, delivery order type contract with an ultimate completion date of October 16, 2023. The contract is not designated as a set-aside and represents a specific product order under AmerisourceBergen's larger $999,999,999 Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XIFAXAN 550 mg tablets. The order, valued at $5,473.81, has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET 60S. The contract is a Firm Fixed Price arrangement with a ceiling value of $33,626.47 and an ultimate completion date of September 20, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXD59Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The contract has a ceiling value of $9,731.30 and an ultimate completion date of September 8, 2023. This order is placed under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/7/23 |